Till sidans topp

Sidansvarig: Webbredaktion
Sidan uppdaterades: 2012-09-11 15:12

Tipsa en vän
Utskriftsversion

BiVap saline vaporization… - Göteborgs universitet Till startsida
Webbkarta
Till innehåll Läs mer om hur kakor används på gu.se

Kontaktformulär








 


OBS! Vill du ha svar, ange e-post eller telefonnummer!




BiVap saline vaporization of the prostate in men with benign prostatic hyperplasia: our clinical experience.

Artikel i vetenskaplig tidskrift
Författare Ayhan Karakose
Özgu Aydogdu
Yusuf Ziya Atesci
Publicerad i Urology
Volym 83
Nummer/häfte 3
Sidor 570-5
ISSN 1527-9995
Publiceringsår 2014
Publicerad vid
Sidor 570-5
Språk en
Länkar dx.doi.org/10.1016/j.urology.2013.1...
www.ncbi.nlm.nih.gov/entrez/query.f...
Ämnesord Aged, Aged, 80 and over, Endoscopy, Erectile Dysfunction, etiology, Humans, Male, Middle Aged, Organ Size, Prostate, pathology, Prostate-Specific Antigen, blood, Prostatic Hyperplasia, complications, physiopathology, surgery, Prostatism, etiology, physiopathology, surgery, Quality of Life, Retrospective Studies, Severity of Illness Index, Sodium Chloride, Surveys and Questionnaires, Transurethral Resection of Prostate, adverse effects, methods, Urodynamics, Volatilization
Ämneskategorier Klinisk medicin, Urologi och njurmedicin, Urologi och andrologi

Sammanfattning

To evaluate the efficacy, safety, and postoperative outcomes of the recently developing endoscopic technique of BiVap saline vaporization of the prostate in patients with benign prostatic obstruction (BPO).Ninety-six patients who underwent transurethral resection of the prostate with BiVap system for BPO and with available data during the 1-year postoperative follow-up period were included in the study. All patients were evaluated at the postoperative 1st, 3rd, 6th, and 12th month, and preoperative and postoperative values of International Prostate Symptom Score (IPSS), quality of life (QoL) score, total prostate-specific antigen, International Index of Erectile Function 15, postvoiding residual urinary volume (PVR), maximum urinary flow rate (Qmax), and average urinary flow rate (Qave) were compared. Statistical analyses were performed with SPSS version 18. A P value <.05 was considered significant.Mean age of the patients was 65.6 ± 7.5 years. Significant improvement was noted for IPSS, Qmax, Qave, PVR, and QoL score by the postoperative first month when compared with the preoperative values. Maximum improvement in the IPSS, Qmax, Qave, PVR, and QoL score was achieved at postoperative 6th, 3rd, 6th, 12th, and 3rd months, respectively. Although total International Index of Erectile Function and subgroup scores decreased at the postoperative first month, all improved to their preoperative levels by the postoperative third month.BiVap system is a safe, effective, and useful technique, which can be easily performed in patients with BPO.

Sidansvarig: Webbredaktion|Sidan uppdaterades: 2012-09-11
Dela:

På Göteborgs universitet använder vi kakor (cookies) för att webbplatsen ska fungera på ett bra sätt för dig. Genom att surfa vidare godkänner du att vi använder kakor.  Vad är kakor?